Day: March 15, 2021

CAMBRIDGE, Mass., March 15, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (NASDAQ: RUBY) (“Rubius”), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announces that it has commenced an underwritten public offering of $150 million of shares of its common stock. Rubius also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering. All the shares in the offering are to be sold by Rubius. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.Rubius intends to use the net proceeds from the offering,...

– Initial dose-escalation data from Phase 1 clinical trial for lead wholly owned CD47 checkpoint inhibitor, SL-172154 (SIRPα-Fc-CD40L), expected in the second half of 2021 –– Dose-escalation data from Phase 1 clinical trial for lead partnered PD-1 checkpoint inhibitor, SL-279252 (PD1-Fc-OX40L), expected in the second half of 2021 –AUSTIN, TX and DURHAM, NC, March 15, 2021 (GLOBE NEWSWIRE) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided recent business highlights.“2020 was a transformative year for Shattuck, and as we look ahead...

Announced Positive Phase 3 RELIEF Study Results for TNX-102 SL 5.6 mg in FibromyalgiaInterim Analysis Results from Second Confirmatory Phase 3 Study, RALLY, Expected in Third Quarter 2021: Interim Cohort EnrolledEfficacy Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in First Quarter 2021Phase 1 Safety Study in Humans of TNX-1800 Expected to Start in Second Half 2021At December 31, 2020, Cash and Cash Equivalents Totaled $77.1 Million; Approximately $110 Million in Gross Proceeds Raised Subsequent to Year-EndCHATHAM, N.J., March 15, 2021 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and full year ended December 31, 2020, and provided an overview of recent...

ROCHESTER, N.Y., March 15, 2021 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced the appointment of Michael Broderick as President and Chief Executive Officer. Mr. Broderick will assume his role effective April 5, 2021, at which time he will also join the Board of Directors. Mr. Broderick brings over 25 years of experience executing profitable growth and business transformation strategies in the aftermarket parts and tire service industry. He most recently served as Executive Vice President of Merchandising and Store Operations Support at Advance Auto Parts where he played a critical role in driving same-store sales growth and operational improvements. Robert Mellor, who has served as Interim Chief Executive Officer since August 2020, will continue...

CLEVELAND, March 15, 2021 (GLOBE NEWSWIRE) — Sotera Health Company (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered by selling stockholders, which include certain affiliates of Warburg Pincus LLC and GTCR, LLC, as well as certain current and former members of management of the Company. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3,750,000 shares of common stock. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company has agreed to pay certain Offering expenses consistent with its obligations under its Amended and Restated Registration Rights Agreement.The...

BIRMINGHAM, Ala., March 15, 2021 (GLOBE NEWSWIRE) — ServisFirst Bancshares, Inc., (NASDAQ: SFBS) (“ServisFirst”), the holding company for ServisFirst Bank, today announces: At a meeting held on March 15, 2021, its Board of Directors declared a quarterly cash dividend of $0.20 per share, payable on April 9, 2021, to stockholders of record as of April 1, 2021.  About ServisFirst Bancshares, Inc.ServisFirst Bancshares, Inc. is a bank holding company based in Birmingham, Alabama. Through its subsidiary, ServisFirst Bank, ServisFirst Bancshares, Inc. provides business and personal financial services from locations in Birmingham, Huntsville, Mobile, Montgomery and Dothan, Alabama, Pensacola, Sarasota and Tampa Bay, Florida, Nashville, Tennessee, Atlanta, Georgia, and Charleston, South Carolina. ServisFirst Bancshares, Inc. files periodic...

MIAMI, March 15, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ:LGVN) (“Longeveron” or the “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced that the underwriters of its previously completed initial public offering of Class A common stock have partially exercised their over-allotment option to purchase an additional 250,000 shares. The thirty-day over-allotment option was granted in connection with the Company’s initial public offering of 2,660,000 shares of Class A common stock at a public offering price of $10.00. After giving effect to the partial exercise of the over-allotment option, the total number of shares sold by Longeveron in the offering increased to 2,910,000 shares, resulting in aggregate...

BEVERLY, Mass., March 15, 2021 (GLOBE NEWSWIRE) — ATN (NASDAQ: ATNI) announced today that its Chief Executive Officer, Michael T. Prior, and Chief Financial Officer, Justin D. Benincasa, are scheduled to present at the Sidoti & Company, LLC Virtual Investor Conference taking place on March 24th-25th, 2021. They are scheduled to present at 1:00PM ET on March 24, 2021 and will be available for one-on-one meetings throughout the day.For more information about ATN International, please visit www.atni.com. Presentations are posted in the Investor Relations section of the Company’s website at http://ir.atni.com/.About ATNATN International, Inc. (Nasdaq: ATNI), headquartered in Beverly, Massachusetts, invests in and operates communications, energy and technology businesses in the United States and internationally, including...

The net asset value (NAV) of Baltic Horizon Fund (the Fund) unit at end of February 2021 amounted to EUR 1.1416 per unit. Compared to the previous month, NAV per unit decreased by -0.23%. The NAV decrease was mainly affected by distribution to unitholders of EUR 1.3 million. Eliminating dividend distribution, the NAV increase during the month would have been +0.73% compared to the previous month. EPRA NAV and EPRA NRV as at the end of February 2021 decreased to EUR 1.2233 per unit, corresponding to a decrease of -0.31% over the last month.Consolidated net rental income for February 2021 amounted to EUR 1.5 million, corresponding to a net rental income increase of EUR 0.2 million compared to the previous month (EUR 1.3 million in January 2021). Successful negotiations with the tenants led to a growth of rental income in February 2021 after...